{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:51:17Z","timestamp":1793670677657,"version":"4.5.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1245\/s10434-025-18000-6","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T16:35:17Z","timestamp":1754843717000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recurrence After Esophagectomy for Esophageal Cancer: High-Volume Center Surveillance Imaging Outcomes"],"prefix":"10.1245","volume":"33","author":[{"given":"Sheuli","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thitiporn","family":"Chobarporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly A.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lye-Yeng","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia P.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"key":"18000_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649-58.e2. https:\/\/doi.org\/10.1053\/j.gastro.2022.05.054.","journal-title":"Gastroenterology."},{"key":"18000_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"key":"18000_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"21","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21:393\u2013422. https:\/\/doi.org\/10.6004\/jnccn.2023.0019.","journal-title":"J Natl Compr Canc Netw."},{"key":"18000_CR4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/s1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090\u20138. https:\/\/doi.org\/10.1016\/s1470-2045(15)00040-6.","journal-title":"Lancet Oncol."},{"key":"18000_CR5","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"PHM van Hagen","year":"2012","unstructured":"van Hagen PHM, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, et al. CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384. https:\/\/doi.org\/10.1056\/NEJMoa1112088.","journal-title":"N Engl J Med."},{"key":"18000_CR6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1200\/jco.2008.17.0506","volume":"27","author":"M Stahl","year":"2009","unstructured":"Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27:851\u20136. https:\/\/doi.org\/10.1200\/jco.2008.17.0506.","journal-title":"J Clin Oncol."},{"key":"18000_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086\u201392. https:\/\/doi.org\/10.1200\/JCO.2007.12.9593.","journal-title":"J Clin Oncol."},{"key":"18000_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/s1470-2045(05)70288-6","volume":"6","author":"BH Burmeister","year":"2005","unstructured":"Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6:659\u201368. https:\/\/doi.org\/10.1016\/s1470-2045(05)70288-6.","journal-title":"Lancet Oncol."},{"key":"18000_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/SLA.0000000000005638","volume":"276","author":"MC Kalff","year":"2022","unstructured":"Kalff MC, Henckens SPG, Voeten DM, et al. Recurrent disease after esophageal cancer surgery: a substudy of the Dutch Nationwide Ivory Study. Ann Surg. 2022;276:806\u201313. https:\/\/doi.org\/10.1097\/SLA.0000000000005638.","journal-title":"Ann Surg."},{"key":"18000_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jamcollsurg.2010.01.006","volume":"210","author":"E Abate","year":"2010","unstructured":"Abate E, DeMeester SR, Zehetner J, et al. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg. 2010;210:428\u201335. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.01.006.","journal-title":"J Am Coll Surg."},{"key":"18000_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejca.2022.09.035","volume":"177","author":"C Panje","year":"2022","unstructured":"Panje C, Hayoz S, Eisterer W, et al. Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: long-term follow-up of the SAKK 75\/08 trial. Eur J Cancer. 2022;177:186\u201393. https:\/\/doi.org\/10.1016\/j.ejca.2022.09.035.","journal-title":"Eur J Cancer."},{"key":"18000_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13304-022-01327-0","volume":"75","author":"MJ Valkema","year":"2023","unstructured":"Valkema MJ, Mostert B, Lagarde SM, et al. The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction. Updates Surg. 2023;75:313\u201323. https:\/\/doi.org\/10.1007\/s13304-022-01327-0.","journal-title":"Updates Surg."},{"key":"18000_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.athoracsur.2021.10.021","volume":"114","author":"C Chang","year":"2022","unstructured":"Chang C, Linden PA, Jiang B, et al. Monitoring for recurrence after esophagectomy. Ann Thorac Surg. 2022;114:211\u20137. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.10.021.","journal-title":"Ann Thorac Surg."},{"key":"18000_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1089\/lap.2017.0069","volume":"27","author":"JP Dolan","year":"2017","unstructured":"Dolan JP, McLaren PJ, Diggs BS, et al. Evolution in the treatment of esophageal disease at a single academic institution: 2004\u20132013. J Laparoendosc Adv Surg Tech A. 2017;27:915\u201323. https:\/\/doi.org\/10.1089\/lap.2017.0069.","journal-title":"J Laparoendosc Adv Surg Tech A."},{"key":"18000_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20:1493\u2013505. https:\/\/doi.org\/10.1016\/S1470-2045(19)30456-5.","journal-title":"Lancet Oncol."},{"issue":"Suppl 3","key":"18000_CR16","doi-asserted-by":"publisher","first-page":"S1292","DOI":"10.1245\/s10434-015-4840-5","volume":"22","author":"K Parry","year":"2015","unstructured":"Parry K, Visser E, van Rossum PS, et al. Prognosis and treatment after diagnosis of recurrent esophageal carcinoma following esophagectomy with curative intent. Ann Surg Oncol. 2015;22(Suppl 3):S1292\u2013300. https:\/\/doi.org\/10.1245\/s10434-015-4840-5.","journal-title":"Ann Surg Oncol."},{"key":"18000_CR17","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1245\/s10434-011-1747-7","volume":"18","author":"H Miyata","year":"2011","unstructured":"Miyata H, Yamasaki M, Kurokawa Y, et al. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18:3353\u201361. https:\/\/doi.org\/10.1245\/s10434-011-1747-7.","journal-title":"Ann Surg Oncol."},{"key":"18000_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/jso.24808","volume":"117","author":"AU Blackham","year":"2018","unstructured":"Blackham AU, Syeda MH, et al. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer. J Surg Oncol. 2018;117:150\u20139. https:\/\/doi.org\/10.1002\/jso.24808.","journal-title":"J Surg Oncol."},{"key":"18000_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","volume":"32","author":"V Oppedijk","year":"2014","unstructured":"Oppedijk V, van der Gaast A, van Lanschot JJ, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014;32:385\u201391. https:\/\/doi.org\/10.1200\/JCO.2013.51.2186.","journal-title":"J Clin Oncol."},{"issue":"1249\u201359","key":"18000_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2018.09.136","volume":"157","author":"A Barbetta","year":"2019","unstructured":"Barbetta A, Sihag S, Nobel T, et al. Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery. J Thorac Cardiovasc Surg. 2019;157(1249\u201359):e5. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.09.136.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"18000_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00268-006-0551-1","volume":"31","author":"G Chen","year":"2007","unstructured":"Chen G, Wang Z, Liu XY, Liu FY. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg. 2007;31:1107\u201314. https:\/\/doi.org\/10.1007\/s00268-006-0551-1.","journal-title":"World J Surg."},{"key":"18000_CR22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00595-012-0133-9","volume":"42","author":"M Sugiyama","year":"2012","unstructured":"Sugiyama M, Morita M, Yoshida R, et al. Patterns and time of recurrence after complete resection of esophageal cancer. Surg Today. 2012;42:752\u20138. https:\/\/doi.org\/10.1007\/s00595-012-0133-9.","journal-title":"Surg Today."},{"key":"18000_CR23","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1245\/s10434-013-2936-3","volume":"20","author":"RL Blom","year":"2013","unstructured":"Blom RL, Lagarde SM, van Oudenaarde K, et al. Survival after recurrent esophageal carcinoma has not improved over the past 18 years. Ann Surg Oncol. 2013;20:2693\u20138. https:\/\/doi.org\/10.1245\/s10434-013-2936-3.","journal-title":"Ann Surg Oncol."},{"key":"18000_CR24","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.JTO.0000437420.38972.fb","volume":"8","author":"F Lou","year":"2013","unstructured":"Lou F, Sima CS, Adusumilli PS, et al. Esophageal cancer recurrence patterns and implications for surveillance. J Thorac Oncol. 2013;8:1558\u201362. https:\/\/doi.org\/10.1097\/01.JTO.0000437420.38972.fb.","journal-title":"J Thorac Oncol."},{"key":"18000_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/XCS.0000000000000801","volume":"237","author":"K Tajima","year":"2023","unstructured":"Tajima K, Koyanagi K, Ozawa S, Kazuno A, Yamamoto M, Shoji Y, et al. Effective postoperative surveillance protocol after thoracoscopic esophagectomy focusing on symptoms in patients with esophageal cancer. J Am Coll Surg. 2023;237:771\u20138. https:\/\/doi.org\/10.1097\/XCS.0000000000000801.","journal-title":"J Am Coll Surg."},{"key":"18000_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1245\/s10434-019-08175-0","volume":"27","author":"Y Ohkura","year":"2020","unstructured":"Ohkura Y, Shindoh J, Ueno M, Iizuka T, Udagawa H. Clinicopathologic characteristics of oligometastases from esophageal cancer and long-term outcomes of resection. Ann Surg Oncol. 2020;27:651\u20139. https:\/\/doi.org\/10.1245\/s10434-019-08175-0.","journal-title":"Ann Surg Oncol."},{"key":"18000_CR27","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00595-020-02173-6","volume":"51","author":"T Morinaga","year":"2021","unstructured":"Morinaga T, Iwatsuki M, Yamashita K, Harada K, Kurashige J, Nagai Y, et al. Oligometastatic recurrence as a prognostic factor after curative resection of esophageal squamous cell carcinoma. Surg Today. 2021;51:798\u2013806. https:\/\/doi.org\/10.1007\/s00595-020-02173-6.","journal-title":"Surg Today."},{"key":"18000_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1186\/s12885-023-11568-w","volume":"23","author":"K Sugawara","year":"2023","unstructured":"Sugawara K, Oka D, Hara H, Yoshii T, Ushijima H, Kudo S, Fukuda T. Survival outcomes of esophageal cancer patients with recurrence after curative treatments. BMC Cancer. 2023;23:1051. https:\/\/doi.org\/10.1186\/s12885-023-11568-w.","journal-title":"BMC Cancer."},{"key":"18000_CR29","doi-asserted-by":"publisher","unstructured":"Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, et al.; CheckMate 577 Investigators. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021;384:1191\u2013203. https:\/\/doi.org\/10.1056\/NEJMoa2032125. Erratum in N Engl J Med. 2023;388:672..","DOI":"10.1056\/NEJMoa2032125"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18000-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:08:54Z","timestamp":1765289334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18000-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["18000"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18000-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,10]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}